New Research and Development and clinical trials drugs to boost the Tuberculosis Drugs Market by by 2026 | Top Key Players are – Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc, Cadila Pharmaceuticals, Novartis AG, Alkem Laboratories Ltd, and Cipla

Drug shortage to treat tuberculosis is a major challenge to effective healthcare in the U.S., with the shortage of drug number tripling from 2007 to 2012. This factor seems to be troublesome and represents a public health threat. U.S. Government Accountability Office reported that there is 16% shortage of anti-infective drugs, including that for tuberculosis.

Various healthcare agencies have organized TB awareness campaigns across the U.S. and had difficulty in accessing medicines and products to diagnose the disease and this is due to shortage, supply disruptions, and high costs of the products. The success story of India drugs market is timely and adequate supply of drugs, though it has been hit the hardest due to poor government policies and tough procurement procedures

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/191

Top Key Players:
- Pfizer
- Lupin Laboratories
- AstraZeneca
- Cadila Pharmaceuticals
- Novartis AG
- Alkem Laboratories
- Cipla

Multidrug-Resistant Tuberculosis (MDR-TB) is highly prevalent worldwide. Around 3% of all new cases diagnosed with TB worldwide have multidrug-resistant tuberculosis and the percentage is more in patients who had already accepted anti-tuberculosis treatment replicating the failure of programs intended to ensure complete cure of patients with tuberculosis. Management of multidrug-resistant tuberculosis is difficult and it requires skilled clinicians at centers with well-equipped laboratory services and DOTS-Plus strategy.

Asia and Africa are the largest markets for tuberculosis drugs, as these regions have the highest prevalence of TB. There are many initiatives taken to control the TB increasing cases. The United Nations’ Millennium Development Goals have framed various strategies to reduce TB prevalence and death rates by 2015, which can be achieved by WHO’s Stop TB Strategy.

According World Health Organization, in 2006, 61% out of 2.5 million new smear positive cases with DOTS, and are all the new smear cases on the year, and the treatment was successful in 85% cases. The estimated global incidence rate of tuberculosis shown decline rate by 0.6% in 2005 and 2006. In 2006, the incidence rate of tuberculosis became stable in the Europe and is declining gradually in the other WHO countries. World Health Organization has an approximation that the occurrence of tuberculosis and death rates are declining faster than the incidence rate.

Ask Questions to Expertise @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/191

Global Tuberculosis Drugs Market, By Therapy Type:
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy

Table of Contents

Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Therapy Type
Market Snippet By Geography
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Pricing Scenario
PEST Analysis
Campaigns and Programs
Distribution Channel
Pipeline Drugs
Prevalence and Incidence
Global Tuberculosis Drugs Market, By Therapy Type, 2014 - 2024 (US$ Million)
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-O-Y Growth Analysis, 2014 - 2024
Segment Trends
First Line Drugs Therapy
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Segment Trend
Isoniazid
Rifampicin
Ethambutol
Pyrazinamide
Streptomycin
Second Line Drugs Therapy
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
Segment Trend
Injections
Fluoroquinolones
Bacteriostatic Agents
Others
Combination Drug Therapy
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)

Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/191

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.